All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 16:11, 22 February 2024 User account Brandy.burch talk contribs was created
- 09:32, 19 February 2024 User account Reenageorgeus talk contribs was created
- 12:50, 12 February 2024 User account Thomas talk contribs was created
- 20:34, 11 February 2024 User account Apetersonweber talk contribs was created
- 08:41, 8 February 2024 User account Jimundlukas talk contribs was created
- 18:14, 7 February 2024 Warner-admin talk contribs uploaded a new version of File:20211027 HemOnc SOP QA.pdf (SOP version 002)
- 21:33, 5 February 2024 User account Marinom talk contribs was created
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 12:35, 2 February 2024 Jwarner talk contribs created page Category:EMA approved in 2024 (Created page with "Category:EMA approved drugs")
- 12:24, 31 January 2024 User account Tyasko Sergey talk contribs was created
- 17:44, 27 January 2024 User account Kristinashipe talk contribs was created
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 02:02, 20 January 2024 Jwarner talk contribs created page Category:Bcl-2 translation inhibitors (Created page with "Category:Apoptosis promoters")
- 02:02, 20 January 2024 Jwarner talk contribs created page Oblimersen (Genasense) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium NCI Drug Dictionary]: The sodium salt of a phosphorothioat...")
- 15:41, 19 January 2024 Jwarner talk contribs created page Category:Ornithine decarboxylase inhibitors (Created page with "Category:Enzyme inhibitors")
- 15:41, 19 January 2024 Jwarner talk contribs created page Eflornithine (Iwilfin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride NCI Drug Dictionary]: A difluoromethylated ornith...")
- 01:26, 19 January 2024 Jwarner talk contribs created page Category:Complement pathway inhibitors (Created page with "Category:Hematology medications")
- 01:25, 19 January 2024 Jwarner talk contribs created page Category:Complement factor D inhibitors (Created page with "Category:Complement pathway inhibitors")
- 01:24, 19 January 2024 Jwarner talk contribs created page Danicopan (ALXN-2040) (Created page with "==Mechanism of action== Complement factor D inhibitor ==Preliminary data== ===Paroxysmal nocturnal hemoglobinuria (PNH)=== #'''ALPHA:'...")
- 18:06, 18 January 2024 Jwarner talk contribs created page Category:Anti-DLL3-CD3 bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 18:05, 18 January 2024 Jwarner talk contribs created page Tarlatamab (AMG-757) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against...")
- 16:49, 14 January 2024 User account Didi64 talk contribs was created
- 12:18, 12 January 2024 Jwarner talk contribs created page Category:Cutaneous T-cell lymphoma medications (investigational) (Created page with "Category:Cutaneous T-cell lymphoma medications")
- 14:46, 8 January 2024 User account Laynelindemann talk contribs was created
- 23:35, 7 January 2024 User account Sorensut talk contribs was created
- 11:42, 6 January 2024 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease medications (Created page with "Category:Supportive medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia medications (Created page with "Category:Leukemia medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant medications (Created page with "Category:Acute lymphoblastic leukemia medications")
- 17:13, 4 January 2024 User account Eddiehu talk contribs was created
- 02:30, 2 January 2024 Jwarner talk contribs created page Category:FDA approved in 2024 (Created page with "Category:FDA approved drugs")
- 03:33, 30 December 2023 Jwarner talk contribs created page Hypereosinophilic syndrome - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. These references provide further insight into the historical development o...")
- 18:32, 20 December 2023 User account Booneg talk contribs was created
- 16:06, 20 December 2023 Warner-admin talk contribs moved page Allogeneic HSCT conditioning regimens to Allogeneic HSCT without leaving a redirect
- 16:05, 20 December 2023 Warner-admin talk contribs deleted page Allogeneic HSCT (content was: "#REDIRECT Allogeneic HSCT conditioning regimens", and the only contributor was "Jwarner" (talk))
- 16:05, 20 December 2023 Warner-admin talk contribs moved page Autologous HSCT conditioning regimens to Autologous HSCT without leaving a redirect
- 16:05, 20 December 2023 Warner-admin talk contribs deleted page Autologous HSCT (content was: "#REDIRECT Autologous HSCT conditioning regimens", and the only contributor was "Jwarner" (talk))
- 13:59, 20 December 2023 Jwarner talk contribs created page Category:FAK inhibitors (Created page with "Category:Tyrosine kinase inhibitors")
- 13:58, 20 December 2023 Jwarner talk contribs created page Repotrectinib (Augtyro) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib NCI Drug Dictionary]: An orally available inhi...")
- 13:50, 19 December 2023 User account Lsurette talk contribs was created
- 00:18, 17 December 2023 Jwarner talk contribs created page Glioblastoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 16:49, 15 December 2023 User account Kaitlyntomic talk contribs was created
- 15:54, 13 December 2023 User account Chadwick1318 talk contribs was created
- 18:40, 12 December 2023 User account BuffyNelson talk contribs was created
- 14:54, 11 December 2023 User account Mais talk contribs was created
- 13:01, 10 December 2023 User account Han talk contribs was created
- 16:54, 8 December 2023 User account Npleat talk contribs was created
- 19:41, 7 December 2023 Dryang talk contribs changed group membership for Ashwinkishtagari from (none) to editors and emailconfirmed
- 19:40, 7 December 2023 User account Ashwinkishtagari talk contribs was created
- 19:30, 7 December 2023 User account Jenniferchoe talk contribs was created
- 19:26, 7 December 2023 Dryang talk contribs changed group membership for Briannabakow from (none) to editors and emailconfirmed